The clinicopathological features of the 2 types of biliary tumor thrombus patients
| Variable | Type I (n = 69) | Type II (n = 133) | P |
|---|---|---|---|
| Age | 51.3 ± 11.0 | 52.9 ± 10.2 | 0.512 |
| Gender (N), male:female | 53/16 | 117/16 | 0.039 |
| AFP (μg/L), < 400: ≥ 400 | 33/36 | 76/57 | 0.208 |
| ALT (U/L), < 40: ≥ 40 | 30/39 | 23/110 | 0.001 |
| Total bilirubin (μmol/L) | 25.97 ± 44.1 | 135.3 ± 123.9 | 0.001 |
| ALP (U/L) | 147.9 ± 73.0 | 262.5 ± 153.1 | 0.001 |
| PT (S) | 12.1 ± 1.0 | 12.5 ± 1.3 | 0.079 |
| Hbs Ag (N), positive: negative | 62/7 | 111/22 | 0.219 |
| HBV-DNA (copies/mL) | 0.479 | ||
| < 1,000 | 52 | 106 | |
| ≥ 1,000 | 17 | 27 | |
| Tumor number, single: multiple | 45/24 | 93/40 | 0.495 |
| Tumor diameter (cm) | 7.34 ± 5.08 | 5.52 ± 3.35 | 0.052 |
| Coexistence of PVTT (n) | 18/69 | 23/133 | 0.148 |
| Child-Pugh A:B | 65/4 | 52/81 | 0.001 |
| Anatomic/local resection | 41/28 | 63/70 | 0.104 |